Bringing a new life into this world is miraculous and rewarding. Gazing into your baby’s tiny eyes while holding them is blissful. Yet this joy and sense of fulfillment come with challenges. Support, guidance and health education are needed the most in the postpartum period to empower women to make informed choices about their own…
Shots:The US FDA approved 10 NDAs and 3 BLA in August 2023, leading to treatments for patients and advances in the healthcare industry. The CDER and CBER approved 89 novel products in 2023In August 2023, the major highlights drugs were Zurzuvae (zuranolone) approval for women with postpartum depression and Veopoz (pozelimab-bbfg) for children…

